Gene · 7337
Papers4,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative Analysis of Alpha and Beta HPV E6 Oncoproteins: Insights into Functional Distinctions and Divergent Mechanisms of Pathogenesis. | Viruses | 2023 | 38005929 | PubTator, text mining | PubMed |
| Study of lncRNAs in Pediatric Neurological Diseases: Methods, Analysis of the State-of-Art and Possible Therapeutic Implications. | Pharmaceuticals (Basel) | 2023 | 38004481 | PubTator, text mining | PubMed |
| NGS Custom Panel Implementation in Patients with Non-Syndromic Autism Spectrum Disorders in the Clinical Routine of a Tertiary Hospital. | Genes (Basel) | 2023 | 38003033 | PubTator, text mining | PubMed |
| Identification and functional analysis of circulating extrachromosomal circular DNA in schizophrenia implicate its negative effect on the disorder. | Clin Transl Med | 2023 | 37997514 | PubTator, text mining | PubMed |
| BioE3 identifies specific substrates of ubiquitin E3 ligases. | Nat Commun | 2023 | 37996419 | PubTator, text mining | PubMed |
| β-arrestin1 is an E3 ubiquitin ligase adaptor for substrate linear polyubiquitination. | J Biol Chem | 2023 | 37981209 | PubTator, text mining | PubMed |
| A primate nigrostriatal atlas of neuronal vulnerability and resilience in a model of Parkinson's disease. | Nat Commun | 2023 | 37980356 | PubTator, text mining | PubMed |
| Nona-Arginine Mediated Anti-E6 ShRNA Delivery Suppresses the Growth of Hela Cells in vitro. | Iran Biomed J | 2023 | 37978985 | PubTator, text mining | PubMed |
| Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies. | Explor Target Antitumor Ther | 2023 | 37970206 | PubTator, text mining | PubMed |
| The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment. | Cell Biosci | 2023 | 37968699 | PubTator, text mining | PubMed |
| Unveiling the Association between HPV and Pan-Cancers: A Bidirectional Two-Sample Mendelian Randomization Study. | Cancers (Basel) | 2023 | 37958321 | PubTator, text mining | PubMed |
| Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions. | BMC Womens Health | 2023 | 37957634 | PubTator, text mining | PubMed |
| The Post-Translational Role of UFMylation in Physiology and Disease. | Cells | 2023 | 37947621 | PubTator, text mining | PubMed |
| Age of diagnosis for children with chromosome 15q syndromes. | J Neurodev Disord | 2023 | 37936142 | PubTator, text mining | PubMed |
| 9-oxo-ODAs suppresses the proliferation of human cervical cancer cells through the inhibition of CDKs and HPV oncoproteins. | Sci Rep | 2023 | 37932321 | PubTator, text mining | PubMed |
| Stem cell models of Angelman syndrome. | Front Cell Dev Biol | 2023 | 37928900 | PubTator, text mining | PubMed |
| Analysis of Human microRNA Expression Profiling During Diquat-Induced Renal Proximal Tubular Epithelial Cell Injury. | J Inflamm Res | 2023 | 37927960 | PubTator, text mining | PubMed |
| c-MYC-dependent transcriptional inhibition of autophagy is implicated in cisplatin sensitivity in HPV-positive head and neck cancer. | Cell Death Dis | 2023 | 37925449 | PubTator, text mining | PubMed |
| Research Progress of Immuno-Inhibitory Receptors in Gynecological Cervical Cancer. | Technol Cancer Res Treat | 2023 | 37908109 | PubTator, text mining | PubMed |
| Contextual fear memory impairment in Angelman syndrome model mice is associated with altered transcriptional responses. | Sci Rep | 2023 | 37903805 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7337/papers?page=14